Sunesis Pharmaceuticals Announces Withdrawal of European Marketing Authorization Application (MAA) for Vosaroxin as a Treatment for Relapsed/Refractory AML

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to Sunesis Pharmaceuticals Announces Withdrawal of European Marketing Authorization Application (MAA) for Vosaroxin as a Treatment for Relapsed/Refractory AML
SUNESIS PHARMA (NASDAQ: SNSS) Delayed: 5.32 --0 (-0%)
Previous Close $5.32    52 Week High $5.00 
Open $0.43    52 Week Low $0.44 
Day High $5.32    P/E N/A 
Day Low $5.32    EPS $-0.60 
Volume 94,317